Novel Technologies in Periprosthetic Joint Infections: Emerging Therapeutics

Area of Science:

• Orthopedics
• Infectious Diseases
• Biotechnology

Background:

• Periprosthetic joint infection (PJI) is a major complication of total joint arthroplasty, leading to significant morbidity and high treatment costs.
• Current treatments, like two-stage revision, have limitations including prolonged hospitalization and variable success rates.
• Despite advancements, PJI management success rates have stagnated, necessitating innovative therapeutic strategies.

Purpose of the Study:

• To review emerging technologies with the potential to revolutionize the treatment of periprosthetic joint infection (PJI).
• To explore novel approaches that address the limitations of current PJI management strategies.

Main Methods:

• Review of seven emerging technologies for PJI treatment.
• Discussion of mechanisms including electromagnetic induction heating, monoclonal antibodies (TRL1068), continuous irrigation spacer systems, antibiotic-loaded polyethylene, bacteriophage therapy, ClpP-activating antibiotics, and photothermal therapy with D-amino acids.

Main Results:

• Electromagnetic induction heating disrupts biofilms and enhances bacterial clearance.
• TRL1068 antibodies target biofilms, improving antibiotic penetration and immune clearance.
• Continuous irrigation, antibiotic-loaded materials, bacteriophages, ClpP activators, and photothermal therapy offer localized treatment and biofilm disruption.

Conclusions:

• Emerging technologies show promise for improving PJI treatment efficacy and patient outcomes.
• Further clinical validation is required to integrate these novel approaches into standard PJI management.
• These advancements could significantly enhance infection control and reduce treatment failures in arthroplasty.